Novo Pakistan steps up to support insulin access

Novo Pakistan is actively addressing concerns about insulin access for people with diabetes in the country. With an estimated 33 million Pakistanis living with diabetes and over one million relying on insulin, the company is collaborating with partners to ensure continuity of treatment. General Manager Mehtaz Sultan Khan emphasized Novo's century-long commitment to diabetes care and the critical need for reliable insulin access, pledging support for patients. Novo Pakistan plans to work with healthcare professionals, policymakers, and patient communities to improve care in the face of the growing diabetes burden. Individuals concerned about their insulin can consult healthcare professionals or utilize NovoCare.pk for resources and support.